Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group.
about
Docetaxel plus cisplatin is effective for patients with metastatic breast cancer resistant to previous anthracycline treatment: a phase II clinical trialModified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study.γ-tocotrienol enhances the chemosensitivity of human oral cancer cells to docetaxel through the downregulation of the expression of NF-κB-regulated anti-apoptotic gene products.Curative treatment can be an option for patients with metastatic squamous cell cancer of the head and neckEnd points for new agents in induction chemotherapy for locally advanced head and neck cancers.Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neckInterstitial docetaxel (taxotere), carmustine and combined interstitial therapy: a novel treatment for experimental malignant glioma.Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck.Taxanes in head and neck cancer.Systemic therapy in head and neck cancer: changing paradigm.Docetaxel in the management of patients with head and neck squamous cell carcinoma.Induction chemotherapy of docetaxel and Cisplatin for the elderly patients with squamous cell carcinoma of the head and neck.Can the status of the breast and ovarian cancer susceptibility gene 1 product (BRCA1) predict response to taxane-based cancer therapy?Management of recurrent head and neck cancer: recent progress and future directions.Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase II study.Docetaxel/cisplatin as first-line chemotherapy in patients with head and neck carcinoma: a phase II trial.A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer.A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.Neoadjuvant docetaxel and cisplatin chemotherapy followed by local irradiation is highly active on locoregionally advanced squamous cell carcinoma of the head and neck.Topoisomerase expression in oral squamous cell carcinoma: relationship with cancer stem cells profiles and lymph node metastasis.RASSF1A and ERCC1 expression levels might be predictive of prognosis in advanced, recurrent, and metastatic squamous cell carcinoma of the head and neck treated with docetaxel and cisplatin.
P2860
Q24799659-2F3AB798-FE85-4485-93C0-E9AEAA4BA64FQ33436548-5D3DFECF-DDAE-4268-AF1A-F47BBB359750Q34471481-32B119F2-9879-4128-BD68-347EB6D728B0Q34742875-D7C902C4-3A80-46CB-B94F-9BC1046964F4Q34784828-0D1CF1D9-F1ED-46A5-B360-17A128CB5608Q35056376-7A0B1879-3F79-42B3-B4B7-353F41D55562Q35607459-0BA8E959-3FCA-4EC7-93E8-984820F2B1E2Q35986419-6B64E7D0-2FC4-461E-8D53-09C0E87F80D6Q36429649-F4FD737F-E68C-4575-B730-7251C85F667EQ36627358-FD39B6D5-0AAF-4F51-96EA-EC583E11E737Q37202758-510F1447-4933-4E45-B181-CAD674C574C1Q37336466-1B3DA50A-6DCF-4120-91CC-E6FD3FE74F56Q37349840-74058F47-A1BA-47D2-AD7B-662239D71BD4Q37921278-A3E2D99E-4B56-4390-A696-F9131AFF0E6AQ43906898-7E5B3014-5984-450F-8C54-4630587BA687Q44062360-3BBED51B-359D-4A02-9F97-37C78342D21FQ44180988-946D4767-D1E0-43EC-ACA8-825045E51CD1Q44231664-A8EE2C26-8D62-4BB6-9EF0-E1EC37C32152Q46959241-F136B39F-640B-437F-B635-6C617FF67D38Q47657563-9C72CDE9-6FF8-42D0-95F4-9555ED9D6B76Q53134485-BD0925BE-2EE6-4AC7-9938-B1A3D6C633B7
P2860
Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Docetaxel and cisplatin: an ac ...... Early Clinical Studies Group.
@ast
Docetaxel and cisplatin: an ac ...... Early Clinical Studies Group.
@en
Docetaxel and cisplatin: an ac ...... Early Clinical Studies Group.
@nl
type
label
Docetaxel and cisplatin: an ac ...... Early Clinical Studies Group.
@ast
Docetaxel and cisplatin: an ac ...... Early Clinical Studies Group.
@en
Docetaxel and cisplatin: an ac ...... Early Clinical Studies Group.
@nl
prefLabel
Docetaxel and cisplatin: an ac ...... Early Clinical Studies Group.
@ast
Docetaxel and cisplatin: an ac ...... Early Clinical Studies Group.
@en
Docetaxel and cisplatin: an ac ...... Early Clinical Studies Group.
@nl
P2093
P356
P1433
P1476
Docetaxel and cisplatin: an ac ...... Early Clinical Studies Group.
@en
P2093
A R Hanauske
A S Planting
A Schrijvers
D Schrijvers
P Schöffski
P304
P356
10.1023/A:1008360323986
P577
1999-01-01T00:00:00Z